Twist Bioscience
TWST
222 hedge funds and large institutions have $6.06B invested in Twist Bioscience in 2020 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 68 increasing their positions, 70 reducing their positions, and 30 closing their positions.
102% more capital invested
Capital invested by funds: $3.01B → $6.06B (+$3.05B)
100% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 30
80% more funds holding in top 10
Funds holding in top 10: 5 → 9 (+4)
15% more funds holding
Funds holding: 193 → 222 (+29)
0.74% more ownership
Funds ownership: 88.9% → 89.64% (+0.74%)
3% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 70
15% less call options, than puts
Call options by funds: $25.2M | Put options by funds: $29.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$301M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$149M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$126M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$88.8M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
+$50.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$83.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$72.1M |
| 3 |
State Street
Boston,
Massachusetts
|
-$37.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$35.2M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$30.5M |
TWST Hedge Fund Activity: Q4 2020 in Review
222 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2020, worth a combined $6.06B — up 102% from $3.01B a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new TWST positions and 30 closed out — a net gain of 30 holders — while 68 added to existing stakes and 70 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $301M. The largest seller was JP Morgan Chase, cutting an estimated $83.2M.
- 222 institutional investors held Twist Bioscience (TWST) as of Q4 2020, up from 193 in Q3 2020.
- Funds reported $6.06B of Twist Bioscience stock for Q4 2020, up 102% quarter-over-quarter.
- 60 funds opened new Twist Bioscience positions in Q4 2020 and 30 closed out, a net change of +30 holders.
- The largest Twist Bioscience buyer in Q4 2020 was ARK Investment Management, an estimated $301M added.
- The largest Twist Bioscience seller in Q4 2020 was JP Morgan Chase, an estimated $83.2M sold.
Based on aggregated 13F filings for Q4 2020.